Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Status Epilepticus Global Clinical Trials Review, H2, 2014


News provided by

Reportlinker

Aug 11, 2014, 07:24 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Status Epilepticus Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02280949/Status-Epilepticus-Global-Clinical-Trials-Review-H2-2014.html

Status Epilepticus Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Status Epilepticus Global Clinical Trials Review, H2, 2014" provides data on the Status Epilepticus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Status Epilepticus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Status Epilepticus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Status Epilepticus 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Status Epilepticus to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Status Epilepticus to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Status Epilepticus 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Status Epilepticus Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Sage Therapeutics 30
Clinical Trial Overview of Sage Therapeutics 30
Ligand Pharmaceuticals, Inc. 31
Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 31
Mylan Inc. 32
Clinical Trial Overview of Mylan Inc. 32
Clinical Trial Overview of Top Institutes / Government 33
Assistance Publique - Hopitaux de Paris 33
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 33
Eunice Kennedy Shriver National Institute of Child Health and Human Development 34
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 34
Xuanwu Hospital Capital Medical University 35
Clinical Trial Overview of Xuanwu Hospital Capital Medical University 35
University of Malawi 36
Clinical Trial Overview of University of Malawi 36
Postgraduate Institute of Medical Education and Research 37
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 37
Shiraz University of Medical Sciences 38
Clinical Trial Overview of Shiraz University of Medical Sciences 38
University of Virginia 39
Clinical Trial Overview of University of Virginia 39
Hillel Yaffe Medical Center 40
Clinical Trial Overview of Hillel Yaffe Medical Center 40
All India Institute of Medical Sciences 41
Clinical Trial Overview of All India Institute of Medical Sciences 41
University of Michigan 42
Clinical Trial Overview of University of Michigan 42
Five Key Clinical Profiles 43
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables

Status Epilepticus Therapeutics, Global, Clinical Trials by Region, 2014* 7
Status Epilepticus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Status Epilepticus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Status Epilepticus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Status Epilepticus Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Status Epilepticus Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Status Epilepticus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Status Epilepticus to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Status Epilepticus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Status Epilepticus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Status Epilepticus to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Status Epilepticus Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Status Epilepticus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Status Epilepticus Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Status Epilepticus Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Status Epilepticus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Status Epilepticus Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Status Epilepticus Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Status Epilepticus Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Status Epilepticus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Status Epilepticus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Status Epilepticus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Status Epilepticus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Status Epilepticus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Sage Therapeutics, 2014* 30
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Ligand Pharmaceuticals, Inc., 2014* 31
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2014* 32
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 33
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 34
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Xuanwu Hospital Capital Medical University, 2014* 35
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Malawi, 2014* 36
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2014* 37
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 38
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014* 39
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillel Yaffe Medical Center, 2014* 40
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 41
Status Epilepticus Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 42

List of Figures

Status Epilepticus Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Status Epilepticus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Status Epilepticus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Status Epilepticus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Status Epilepticus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Status Epilepticus Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Status Epilepticus Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Status Epilepticus to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Status Epilepticus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Status Epilepticus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Status Epilepticus to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Status Epilepticus Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Status Epilepticus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Status Epilepticus Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Status Epilepticus Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Status Epilepticus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Status Epilepticus Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Status Epilepticus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Status Epilepticus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Status Epilepticus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Status Epilepticus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Status Epilepticus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68


To order this report: Status Epilepticus Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02280949/Status-Epilepticus-Global-Clinical-Trials-Review-H2-2014.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.